A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes

Summary

The purpose of this study is to evaluate the compatibility and safety of LY900014 and insulin lispro with an external continuous subcutaneous insulin infusion system in adult participants with type 1 diabetes.

Timeline

Start

2018-02-21

Primary completion

2018-09-04

Completion

2018-09-04

Outcome

Missed primary endpoint

registry analysis (superiority test); Insulin Lispro (Humalog®) vs LY900014; p = 0.375 NCT03433677 ↗

Drugs

Indications